Der foreligger ingen kliniske data herfor, men det er sandsynligt at eliminationen af alendronat via nyrerne, ligesom hos dyr, vil være reduceret hos patienter med nyreinsufficiens.
Although no clinical information is available, it is likely that, as in animals, elimination of alendronate via the kidney will be reduced in patients with impaired renal function.